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Abstract 
Background: Patients with blunt solid organ injuries (SOI) are at risk for venous 
thromboembolism (VTE) and VTE prophylaxis is crucial. However, little is known about the 
safety of early prophylactic administration of heparin in these patients. 
Methods: Retrospective study including adult trauma patients with SOI (liver, spleen, kidney) 
undergoing non-operative management (NOM) 01/2009-12/2014. Three groups were 
distinguished: prophylactic heparin (low molecular weight heparin [LMWH] or low-dose 
unfractionated heparin [LDUH]) ≤72h after admission (‘early heparin-group’), >72h after 
admission (‘late heparin-group’), and no heparin (‘no heparin-group’). Patient and injury 
characteristics, transfusion requirements, and outcomes (failed NOM, VTE, mortality) were 
compared between the three groups. 
Results: Overall, 179 patients were included; 44.7% in the ‘early heparin-group’, 34.6% in the 
‘late heparin-group’, and 20.8% in the ‘no heparin-group’. In the ‘late heparin-group’, the ISS 
was significantly higher than in the ‘early’ and ‘no heparin-groups’ (median 29.0 vs. 17.0 vs. 
19.0; p<0.001). The overall NOM failure rate was 3.9%. Failed NOM was significantly more 
frequent in the ‘no heparin-group’ compared to the ‘early’ and ‘late heparin-groups’ (10.8% vs. 
3.2% vs. 1.3%; p=0.043). In the ‘early heparin-group’ 27.5% patients suffered from a high-grade 
SOI; none of these patients failed NOM. Mortality did not differ significantly. Although not 
statistically significant, VTE were more frequent in the ‘no heparin-group’ compared to the 
‘early’ and ‘late heparin-groups’ (10.8% vs. 4.8% vs. 1.3%; p=0.066). 
Conclusion: In patients with SOI, heparin was administered early in a high percentage of patients 
and was not associated with an increased NOM failure rate or higher in-hospital mortality. 
Background 
Non-operative management (NOM) of solid organ injuries (SOI) increased significantly in the 
last two decades.1 At present, NOM is an established treatment approach for hemodynamically 
stable trauma patients with SOI.2, 3 
The risk of failed NOM in trauma patients with SOI, i.e. rebleeding increases with the injury 
grade, amount of hemoperitoneum, occurrence of an arterio-venous fistula, and contrast 
extravasation on the computed tomography (CT) scan on admission and decreases over time.4, 5 
Rebleeding rates as high as 32% have been reported in patients with SOI and contrast 
extravasation on the CT scan.6 On the other hand, trauma patients are at risk for venous 
thromboembolism (VTE).7, 8 In orthopedic9, 10 and elective surgical11, 12 patients, low molecular 
weight heparin (LMWH) is currently the standard agent for postoperative VTE prophylaxis. 
To date, four studies evaluated postinjury prophylactic heparin administration in trauma patients 
with blunt SOI.13-16 However, these studies differed substantially with regard to the study design, 
patient characteristics, and the timepoint of heparin administration. Furthermore, only a limited 
number of patients that received heparin early (within 72 hours after hospital admission) were 
included. 
Based on our previous study that assessed prophylactic LMWH administration in trauma 
patients, a new policy of heparin prophylaxis was introduced at our institution.4 In patients with 
any grade of SOI prophylactic LMWH or low-dose unfractionated heparin (LDUH) was 
administered within 48 to 72 hours after hospital admission, unless patients had contraindications 
for prophylactic anticoagulation therapy (e.g. traumatic brain injury).
The aim of the current study was to investigate the impact of early prophylactic LMWH or 
LDUH administration on failed NOM and VTE in patients with liver, splenic, and kidney 
injuries after the introduction of this new policy.
Methods 
Approval for the current study was obtained from the Institutional Revision Board of the Bern 
University Hospital (KEK 067/14). 
 
Patient Selection 
This is a retrospective study including adult trauma patients with liver, splenic, and/or renal 
injuries that were admitted to the Bern University Hospital from 01/01/2009 to 12/31/2014. The 
Bern University Hospital is a tertiary facility that includes a busy trauma center with a yearly 
admission rate of approx. 500 major trauma patients (Injury Severity Score [ISS] >15). 
Inclusion criteria were age >16 years, and blunt SOI with attempted NOM. NOM was defined as 
no surgery and no angioembolization of the SOI in the first 6 hours after hospital admission and 
was performed in hemodynamically stable patients only. The standard of care for NOM included 
continuous monitoring of vital signs in the Intermediate Care or Intensive Care Unit, clinical 
reevaluation every 6 to 8 hours, and serial hemoglobin levels every 6 to 8 hours. 
A surgical or radiological intervention ≥ 6 hours after hospital admission was defined as failed 
NOM. Patients that died during the first 72 hours after hospital admission were excluded. 
 
Data Collection 
Data were retrospectively collected using the institutional trauma registry (Trauma Audit and 
Research Network [TARN] database) and electronic patient records. Data collection included 
type and time of prophylactic heparin (LMWH or LDUH) administration, patient characteristics 
(sex, age), injury characteristics (Abbreviated Injury Scale [AIS; head, chest, abdomen, 
extremities, and external], Injury Severity Score [ISS], Glasgow Coma Scale [GCS]), the injured 
solid organ (liver, spleen, kidney, pancreas), presence of hemoperitoneum (on abdominal CT 
scans, massive hemoperitoneum defined as blood in all four quadrants), hypotension at 
Emergency Department admission (systolic blood pressure < 90 mmHg), hollow organ injuries, 
severe pelvic or lower extremity fractures (AIS extremities ≥ 3), transfused blood products in the 
24 h after admission (Packed Red Blood Cells [PRBC], Fresh Frozen Plasma [FFP], platelets 
[PLT]), risk factors for failed NOM, and outcome variables (in-hospital mortality, VTE, and 
failed NOM). 
Risk factors for failed NOM were defined as follows: high-grade injuries, contrast extravasation, 
pseudoaneurysm, massive hemoperitoneum, and vessel truncation.4, 6, 13 
VTE included venous thrombosis and pulmonary embolism, diagnosed by Doppler Ultrasound or 
high-resolution chest computed tomography (CT) scanning. No routine VTE screening was 
performed. Diagnostic imaging was performed only if clinical symptoms for VTE were present. 
Abdominal CT scans were obtained on admission in all patients. Based on abdominal CT scans, 
SOI were classified according to the American Association for the Surgery of Trauma (AAST) 
Organ Injury Scale (OIS), and categorized into low-grade (OIS ≤ 3) and high-grade (OIS > 3) 
injuries.17, 18 
 
Thromboembolic Prophylaxis with Heparin 
In patients selected for NOM, heparin (LMWH or LDUH) prophylaxis was started at the 
discretion of the attending surgeon within 24-72 hours after hospital admission unless the patient 
had contraindications such as traumatic brain injury. The following heparin products were 
administered: Heparin (Liquemin®, Calciparin®) 10,000 IU/24h, Enoxaparin (Clexane®) 
40mg/24h, or Nadroparin (Fraxiparin®). 
Included patients were dived into three groups: thromboembolic prophylaxis with heparin ≤72 
hours after hospital admission (‘early heparin group’), thromboembolic prophylaxis with heparin 
>72 hours after hospital admission (‘late heparin group’), and no prophylaxis with heparin during 
the hospital stay (‘no heparin group’). 
Patient characteristics, injury characteristics, transfusion requirements within the first 24 hours 
after admission, and outcome variables of the three groups were compared in univariate analysis. 
Factors affecting the timing of the heparin prophylaxis, i.e. early versus late heparin 
administration, were analyzed with multivariate analysis. 
 
Statistical analysis 
Normality of distribution was assessed using histograms, skewness, and the Shapiro-Wilk test. In 
univariate analysis, categorical variables were compared using the chi-square test and continuous 
variables using the Kruksal-Wallis test, as appropriate. Results were reported as numbers and 
percentages, means and standard deviations (SD), or medians and interquartile ranges (IQR), as 
appropriate. P-values ≤ 0.05 were considered statistically significant. 
The effect of clinically important predictor variables (sex, age, AIS 
head/chest/abdomen/extremities/external ≥ 3, GCS, hypotension on admission, injured solid 
organ, and PRBC, FFP and PLT transfusion) on the timing of heparin prophylaxis (early versus 
late) was analyzed in backward stepwise multivariate logistic regression analysis. The 
association of the clinically important predictor variables and early versus late heparin 
administration was analyzed in univariate analysis and entered in the regression model if the p-
value was < 0.1. Results were reported as odds ratio (OR) and 95% confidence interval (CI). 
Interactions between the predictor variables were tested using separate logistic regression 
analyses. Multicollinearity was assessed using the variance inflation factor (VIF). A VIF < 5 was 
assumed to exclude significant collinearity. The goodness-of-fit of the regression model was 
assessed using Hosmer-Lemeshow statistics. 
All statistical analyses were performed using SPSS Statistics (Version 22, IBM Corporation, 
Armonk, NY).
Results 
Included Patients and Baseline Characteristics 
A total of 271 adult trauma patients with blunt SOI were admitted during the 6-years study 
period. Of these, 179 patients fulfilled the inclusion criteria and were enrolled into the analysis. 
The ‘early heparin group’ comprised 80 patients (44.7%), the ‘late heparin group’ 62 patients 
(34.6%), and the ‘no heparin group’ 37 patients (20.7%). (Figure 1) 
 
Baseline characteristics of the included patients are shown in Table 1. Patients were 
predominately male (70.4%), had a median age of 38.0 years (IQR 27.9), and a median ISS of 
21.0 (IQR 15.0). The median ISS of patients in the ‘late heparin group’, was significantly higher 
compared to the median ISS in the ‘early heparin group’ and ‘no heparin group’, respectively 
(29.0 vs. 17.0 vs. 18.0; p<0.001). The percentage of patients receiving FFP within the first 24 
hours was significantly higher in the ‘late heparin group’ compared to the ‘early’ and ‘no heparin 
group’ (24.2% vs. 7.6% vs. 10.8%; p=0.016). In the ‘early heparin group’, severe pelvic and 
lower extremity fractures were significantly more frequent than in the ‘late heparin and ‘no 
heparin groups’ (47.8% vs. 37.1% vs. 18.9%; p=0.012). 
 
Solid Organ Injuries and Timing of Heparin Administration 
The median time of heparin administration was 57 hours (IQR 71) after hospital admission. 
In patients receiving early heparin, 18.8% of the patients with splenic injuries, 30.8% of the 
patients with liver injuries, and 28.0% of the patients with renal injuries had high-grade injuries. 
In patients with splenic injuries, the proportion of patients receiving early, late or no heparin was 
not significantly different. This was also observed in the subgroups of patients with high-grade 
splenic injuries and patients with risk factors for failed NOM. 
In patients with liver or renal injuries, the proportion of patients receiving early, late or no 
heparin was not significantly different, whereas high grade liver injuries and risk factors for 
NOM failure in patients with renal or liver injuries were significantly more frequent in the ‘late 
heparin than in the ‘early’ and ‘no heparin group’. (Table 2) 
 
Outcomes 
Failed NOM occurred only in patients with splenic injuries and was significantly more frequent 
in the ‘no heparin group’ than in the ‘early’ and ‘late heparin group’ (10.8%, 3.2%, and 1.3%, 
respectively; p=0.043). The characteristics of patients with failed NOM are outlined in detail in 
Table 4. 
The occurrence of VTE was not significantly different between the three heparin groups, 
although there was a strong trend towards more VTE in the ‘no heparin group’ compared to the 
‘early’ and ‘late heparin groups’ (10.8%, 4.8%, and 1.3%, respectively; p=0.066) (Table 3). The 
characteristics of patients with VTE are outlined in detail in Table 5. 
In-hospital mortality was not significantly different between the three heparin groups. Only one 
patient from the ‘late heparin group’ died from severe traumatic brain injury (TBI) 11 days after 
admission. 
Factors affecting the timing of heparin prophylaxis 
Multivariate analysis for early versus late heparin prophylaxis included hypotension on 
admission, AIS (head, chest, abdomen, extremities, external) ≥ 3, GCS on admission, and PRBC, 
FFP, and PLT transfusion. AIS abdomen ≥ 3 (OR 4.550, CI 2.100-9.859, p<0.001) and AIS head 
≥ 3 (OR 2.721, CI 1.026-7.212) were identified as independent predictors for late heparin 
prophylaxis. The regression model fit the data well (Hosmer-Lemeshow statistics: Χ2 0.34, df 2, 
p=0.983). No significant interaction or collinearity between the predictor variables of the 
regression model was detected. The VIF was < 4 in all predictor variables.
Discussion 
This study evaluated the timing of LMWH or LDUH administration for prophylaxis of VTE in 
179 trauma patients with SOI undergoing NOM. The overall incidence of failed NOM was low, 
i.e. 3.9%, which is in line with previous studies that reported failed NOM in 3.1 to 7.0% of 
trauma patients with SOI.13, 19-21 However, in another study from our institution that analyzed the 
management of blunt splenic injuries, failed NOM was observed in 21% of patients with high-
grade injuries.22 Of the 80 patients that received heparin early, i.e. before 72 hours after hospital 
admission, only one (1.3%) failed NOM and underwent angioembolization for a grade 4 splenic 
laceration at hospital day seven. 
The proportion of trauma patients that received heparin early was 44.7% in the current study. 
This is the second highest rate of early prophylactic heparin administration reported so far. 
Rostas et al reported early LMWH administration (<72 hours) in 48.0% of included patients. 
However, this study population included less high-grade (OIS ≥ 3) liver and splenic injuries than 
the current study (12.8% vs. 39.2%).15 On the other hand, Eberle et al, in their retrospective 
study including patients with SOI undergoing NOM, reported early LMWH administration in 
only 13.2% of included patients.13 
Not surprisingly, the median ISS and number of patients with severe TBI (AIS head ≥ 3) were 
significantly higher in patients with late compared to early heparin administration. The higher 
injury burden and potential TBI-related bleeding complications most likely delayed heparin 
administration in these patients. This is also supported by the multivariate regression analysis 
that revealed AIS abdomen or head ≥ 3 as independent predictors for late heparin administration. 
The decision to avoid early heparin in these patients was at the discretion of the treating surgeon, 
which is in accordance with our institution’s policy. However, whether higher ISS or severe TBI 
are contraindications for early prophylactic heparin needs to be addressed by future studies. 
In contrast, early heparin administration was significantly more frequent in patients with pelvic 
and severe lower extremity fractures, which are well-known risk factors for VTE.7, 8 Apparently, 
the high risk of VTE in this group of patients did outweigh the risk of bleeding complications 
and therefore, prophylactic heparin was administered earlier. 
Higher organ injury grades have been reported as risk factors for failed NOM in patients with 
splenic23-25, hepatic26, 27, and renal trauma5, 28. Interestingly, in patients with splenic injuries and 
risk factors for failed NOM, no significant difference between the ‘early’, ‘late’ and ‘no heparin 
group’ was found. However, in patients with liver or renal injuries and risk factors for failed 
NOM, late heparin administration was significantly more frequent than early heparin 
administration. It seems that rebleeding from liver or renal injuries was more feared than 
rebleeding from splenic injuries by the treating team. This is not supported by the literature and 
hence we believe that a more liberal use of heparin prophylaxis should be attempted in patients 
with liver or renal injuries. 
In the present study, although statistically not significant, there was a strong trend towards less 
thromboembolic complications in patients receiving early prophylactic heparin. Joseph et al 
compared early (< 48 hours) vs. intermediate (48 to 72 hours) vs. late (> 72 hours) VTE 
prophylaxis with LMWH in a propensity score-matched analysis of trauma patients with SOI 
undergoing NOM. In this study, the frequency of thromboembolic complications was also not 
significantly different between the three groups. Nevertheless, in the early prophylaxis group no 
thromboembolic event was reported, whereas the frequency of thromboembolic events was 3.4% 
in both, the intermediate and late VTE prophylaxis group.14 The early administration of 
prophylactic heparin in trauma patients with SOI therefore may reduce the risk for 
thromboembolic complications, although this has not been proved so far, most likely due to 
underpowered studies. Further investigation of the effect of early heparin prophylaxis on VTE 
rates in patients with SOI in larger clinical trials is therefore warranted. 
Finally, this study has some inherent limitations. Besides the usual limitations of retrospective 
studies, this single-center study may be underpowered to detect significant differences of 
infrequent events such as NOM failure, VTE or in-hospital mortality. In addition, no 
standardized VTE screening was performed and therefore only clinically apparent VTE were 
assessed. 
In conclusion, in patients with SOI undergoing NOM, heparin was administered early in a high 
percentage of patients and was not associated with an increased NOM failure rate or higher in-
hospital mortality. Based on these results, the early administration of prophylactic heparin may 
be safe in patients with SOI undergoing NOM.
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Trauma patients with 
solid organ injuries 
Bern University Hospital 
01/01/2009 – 12/31/2014 
n=271 
Non-operative management 
n=179 
Early heparin group 
n=80 (44.7%) 
Late heparin group 
n=62 (34.6%) 
No heparin group 
n=37 (20.7%) 
Excluded 
Death within 72 h: n=16 
Transfer to other hospital: n=15 
Incomplete data: n=12 
Figure 1 Patients included 
Early heparin group: heparin < 72 h after admission; Late heparin group: heparin > 72h after admission. 
Operative management 
(Surgery or coiling < 6 h after 
admission) 
n=49 
 
Table 1 Baseline characteristics 
      
 All patients Early heparin Late heparin No heparin p-value† 
 (n=179) (n=80) (n=62) (n=37)  
Age (years)* 38.0 (27.9) 38.4 (29.4) 36.8 (30.7) 40.3 (21.5) 0.588‡ 
Male gender 126 (70.4) 60 (75.0) 39 (62.9) 27 (73.0) 0.272 
ISS* 21.0 (15.0) 17.0 (11.0) 29.0 (21.0) 18.0 (16.5) <0.001‡ 
AIS head ≥ 3 37 (20.7) 10 (12.5) 20 (32.3) 7 (18.9) 0.015 
AIS chest ≥ 3 104 (58.1) 47 (58.8) 43 (69.4) 14 (37.8) 0.009 
AIS abdomen ≥ 3 84 (46.9) 23 (28.8) 38 (61.3) 23 (62.2) <0.001 
AIS extremities ≥ 3 41 (22.9) 21 (26.3) 16 (25.8) 4 (10.8) 0.145 
GCS ≤ 8 13 (7.3) 4 (5.0) 7 (11.3) 2 (5.4) 0.318 
Severe pelvic/LE fracture 68 (38.0) 38 (47.8) 23 (37.1) 7 (18.9) 0.012 
High grade SOI 76 (42.5) 21 (26.3)) 32 (51.6) 23 (62.2) <0.001 
Hollow viscus injury 2 (1.1) 0 (0.0) 1 (1.6) 1 (2.7) 0.390 
Hypotension at admission 8 (4.5) 1 (1.3) 6 (9.7) 1 (2.7) 0.046 
PRBC first 24 h 49 (27.4) 18 (22.5) 22 (35.5) 9 (24.3) 0.204 
FFP in first 24 h 25 (14.0) 6 (7.6) 15 (24.2) 4 (10.8) 0.016 
PLT first 24 h 10 (5.6) 2 (2.5) 7 (11.3) 1 (2.7) 0.054 
Values are numbers (percentages) unless indicated otherwise. *Values are medians (interquartile range). 
†Chi-square test. ‡Kruksal-Wallis test. 
ISS: Injury Severity Score, AIS: Abbreviated Injury Scale, GCS: Glasgow Coma Scale, LE: lower extremity, SOI: solid organ injury, 
PRBC: packed red blood cells, FFP: fresh frozen plasma. 
 
	  
 
Table 2 Solid Organ Injuries and Timing of Heparin Administration 
      
 Total Early heparin Late heparin No heparin p-value† 
Splenic injury 69 (100) 32 (46.4) 20 (29.0) 17 (24.6) 0.375 
High grade injury 21 (100) 6 (28.6) 7 (33.3) 8 (38.1) 0.106 
Risk factors for failed NOM1 16 (100) 5 (31.3) 5 (31.3) 6 (37.5) 0.292 
      
Liver injury 97 39 (40.2) 37 (38.2) 21 (21.6) 0.406 
High grade injury 37 (100) 9 (24.3) 19 (51.4) 9 (24.3) 0.035 
Risk factors for failed NOM1 30 (100) 6 (20.0) 17 (56.7) 7 (23.3) 0.015 
      
Renal injury 58 25 (43.1) 20 (34.5) 13 (22.4) 0.916 
High grade injury 24 (100) 7 (29.2) 9 (37.5) 8 (33.3) 0.156 
Risk factors for failed NOM2 14 (100) 2 (14.3) 8 (57.1) 4 (28.6) 0.037 
Values are numbers (percentages). 
†Chi-square test. 
1Contrast extravasation, pseudoaneurysm, massive hemoperitoneum, and vessel truncation. 
2Contrast extravasation, pseudoaneurysm, arteriovenous ﬁstula, and vessel truncation. 
NOM: non-operative management. 
 
	  
 
Table 3 Univariate analysis of outcome variables 
      
 All patients Early heparin Late heparin No heparin p-value† 
 (n=179) (n=80) (n=62) (n=37)  
Failed NOM 7 (3.9) 1 (1.3) 2 (3.2) 4 (10.8) 0.043 
In-hospital mortality 1 (0.6) 0 (0.0) 1 (1.6) 0 (0.0) 0.390 
Venous thrombo-embolism 8 (4.5) 1 (1.3) 3 (4.8) 4 (10.8) 0.066 
Values are numbers (percentages) 
†Chi-square test. 
NOM: non-operative management. 
 
 
 
 
  
Table 4 Characteristics of patients with failed non-operative management 
           
Patient Sex Age Mechanism of 
injury 
Solid organ 
injury* 
Associated injuries ISS Intervention Timing 
intervention 
Start 
heparin 
Risk 
factors 
  (years)      (days after admission) 
(days after 
admission)  
1 m 41 MVC spleen grade 3, 
liver  grade 2 
- 9 splenectomy 17 - AV-fistula 
2 m 54 Fall more than 2 m spleen grade 3, 
liver grade 2 
ribs, scapula, spinefractures 22 splenectomy 6 - LAH 
3 m 19 MVC spleen grade 4 femur- and  clavicle fracture 25 splenectomy 2 - LAH 
4 f 62 Fall less than 2 m spleen grade 4 spine fractures with spinal cord 
contusion, rib fractures with 
hematopneumothorax 
18 angioembolization 7  - 
5 m 57 MVC liver grade 2, 
renal grade 2, 
pancreas grade 2 
complex cerebral & cervical 
injury, rib fractures with lung 
contusion, hemato-pneumothorax 
bilateral 
41 splenectomy 
pancreatectomy 
10 16 LAH 
6 m 19 Fall more than 2 m spleen grade 4 - 16 angioembolization 6 5 AV-fistula, 
LAH 
7 f 40 MVC spleen grade 4 cervical & thoracic spine fracture, 
multiple rib fractures with 
hemato-pneumothorax, complex 
hip fracture 
34 splenectomy 1 - Contrast 
extravasation 
*According to the American Association for the Surgery of Trauma Organ Injury Scale. 
SOI: solid organ injury, ISS: Injury Severity Score, MVC: motor vehicle collision, AV: arterio-venous, LAH: large amount of hemoperitoneum. 
 Table 5 Characteristics of patients with venous thromboembolism 
        
Patient Sex Age Solid organ injury Associated injuries Start heparin VTE Time of VTE 
diagnosis 
  (years)   (days after admission)  
(days after 
admission) 
1 m 31 spleen grade 4 traumatic brain injury, hematopneumothorax, 
complex injuries of upper & lower extremities 
4 PE 16 
2 f 44 liver grade 2 hematopneumothorax, rib fractures - PE 4 
3 m 51 spleen grade 3 pelvic ring fracture, complex tibia fracture 5 PE 6 
4 m 40 liver grade 2, spleen grade 3 pelvic ring fracture - DVT 50 
5 m 54 liver grade 1 hematopneumothorax, spine fracture, pelvic 
fracture 
6 PE 52 
6 m 19 spleen grade 4 clavicle fracture, femur fracture 2 PE 30 
7 m 72 liver grade 2, renal grade 2 hematopneumothorax 0 DVT at admission 
8 f 74 liver grade 2 traumatic brain injury, spine fracture, upper and 
lower extremity fractures 
- PE 30 
*According to the American Association for the Surgery of Trauma Organ Injury Scale. 
VTE: venous thromboembolism, PE: pulmonary embolism, DVT: deep venous thrombosis. 
